Chief Executive Officer at Biostax.
Earliest Form D on file: Jun 2026
Low-dose naltrexone for HIV and immune restoration
Biotech, Winter Park FL
Signed as Chief Executive Officer
$0
sold of $7.5M offered
Form D
LinkedIn
Browse by sector
Browse by state